An Exploratory Study to Investigate the Immunomodulatory Activity of Various Dose Levels of Anti Programmed-Deach-1 (PD-1) Antibody (BMS-936558) in Subjects with Metastatic Clear Cell Renal Cell Carcinoma (RCC)
What is the purpose of this trial?
- 18 Years and older
- Bristol-Myers Squibb
- July 2011
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale2403179